Skip to content

Securing Arterial and Venous devices Effectively in hospitals (The SAVE trial)

Randomised controlled trial of tissue adhesive, bordered polyurethane, or external stabilisation devices versus standard care (standard polyurethane) dressings to prevent intravascular device failure in hospital patients with intravenous and arterial devices: The SAVE Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12611000769987
Acronym
The SAVE Trial
Enrollment
2158
Registered
2011-07-22
Start date
2012-05-08
Completion date
2014-09-12
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Going to hospital usually means having an intravascular device (“IV drip”) in your vein or artery. Almost half of all IV drips fall out or fail because they are not well secured to the skin. This means patients miss out on treatment and have extra painful needlesticks to insert new devices. Serious infections can also occur. This study will find the best dressings to use on IV drips. Patients will have their drips glued in with medical superglue, or have one of two new dressings, compared with current usual care.

Interventions

Patients in this study have intravascular devices (IVDs) used in medical, surgical, anaesthetic and intensive care departments, and include adult and paediatric patients. Consenting patients will have their IVD secured with one of the following randomly assigned dressings and securements: Arm 1: Tissue Adhesive. Tissue Adhesive (TA) is medical grade ‘superglue’ (cyanoacrylate) used mainly to close skin lacerations/wounds as an alternative to sutures and staples. Arm 2: Bordered Polyurethane d

Patients in this study have intravascular devices (IVDs) used in medical, surgical, anaesthetic and intensive care departments, and include adult and paediatric patients. Consenting patients will have their IVD secured with one of the following randomly assigned dressings and securements: Arm 1: Tissue Adhesive. Tissue Adhesive (TA) is medical grade ‘superglue’ (cyanoacrylate) used mainly to close skin lacerations/wounds as an alternative to sutures and staples. Arm 2: Bordered Polyurethane dressing. Bordered polyurethane dressings (BPUs) retain the central polyurethane component of standard polyurethane dressings with an added external adhesive border of foam or cloth fabric. Arm 3: Sutureless Securement Device. Sutureless Stabilization Devices (SSD) are used in addition to SPUs. They have a large adhesive footplate underlying a pad on the skin plus an Intravascular Device-locking clasp, or Arm 4 (Control): Standard Polyurethane dressing. Standard Polyurethane dressings (SPUs) are commercially-made plastic film dressings which are transparent and semi-permeable (to oxygen, carbon dioxide and water vapour). The randomly allocated dressing will be applied until completion of therapy.

Sponsors

Griffith University
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
0 to No maximum
Healthy volunteers
No

Inclusion criteria

1. Informed written consent 2. Intravenous or arterial IVD in situ. 3. IVD scheduled/expected use > 24 hours

Exclusion criteria

1. Non-English speaking patients without interpreter 2. IVD inserted through burned or diseased skin 3. Extremely diaphoretic patients 4. Known allergy to any study product

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 6, 2026